RC
TAK icon

Rexford Capital’s Takeda Pharmaceutical TAK Stock Holding History

Rexford Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Sell
8,370
-70
-0.8% -$1.16K 0.08% 199
2026
Q1 		$156K Sell
8,440
-145
-2% -$2.54K 0.11% 187
2025
Q4 		$134K Sell
8,585
-648
-7% -$9.27K 0.1% 202
2025
Q3 		$135K Hold
9,233
– – 0.1% 199
2025
Q2 		$143K Buy
+9,233
New +$136K 0.12% 192

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Rexford Capital's TAK Position: Q2 2026 in Review

Rexford Capital reduced its Takeda Pharmaceutical (TAK) stake by 0.83% in Q2 2026, selling an estimated $1.16K and leaving 8,370 shares worth $134K. The position accounts for 0.08% of the portfolio, ranked #199.

Rexford Capital first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $156K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Rexford Capital held 8,370 shares of Takeda Pharmaceutical worth $134K as of Q2 2026.
  • Rexford Capital sold 70 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.16K.
  • Takeda Pharmaceutical made up 0.08% of Rexford Capital's portfolio in Q2 2026, its #199 holding.
  • Rexford Capital first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Rexford Capital's Takeda Pharmaceutical position peaked at $156K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.